Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2001
Chrysanthemyl diphosphate synthase: isolation of the gene and characterization of the recombinant non-head-to-tail monoterpene synthase from Chrysanthemum cinerariaefoliumS B Rivera, B D Swedlund, G J King, et al.Antimicrobial Agents and Chemotherapy|July 21, 2022
Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center StudyDeiziane V S Costa, Natalie V S Pham, Rachel A Hays, et al.Applied and Environmental Microbiology|April 16, 2021
Development of Wastewater Pooled Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Congregate Living SettingsLisa M Colosi, Katie E Barry, Shireen M Kotay, et al.Infection and Immunity|February 23, 2013
Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infectionJoshua C Eby, Mary C Gray, Jason M Warfel, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 16, 2010
A rapid and simple isothermal nucleic acid amplification test for detection of herpes simplex virus types 1 and 2Hyun-Jin Kim, Yanhong Tong, Wen Tang, et al.Journal of Clinical Microbiology|March 13, 2015
Multicenter evaluation of Candida QuickFISH BC for identification of Candida species directly from blood culture bottlesAyman M Abdelhamed, Sean X Zhang, Tonya Watkins, et al.Journal of the American Society of Cytopathology|May 5, 2019
From slide sets to sound bites: teaching and learning pathology in the digital ageAnne M Mills, Marisa Meyers-Needham, Robin D LeGallo, et al.Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
Convalescent plasma for preventing critical illness in COVID-19: A phase 2 trial and immune profileJeffrey M Sturek, Tania A Thomas, James D Gorham, et al.Microbiology Spectrum|February 24, 2022
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune ProfileJeffrey M Sturek, Tania A Thomas, James D Gorham, et al.Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
IL-13 is a driver of COVID-19 severityAlexandra N Donlan, Tara E Sutherland, Chelsea Marie, et al.Pageof 13